The Detection of HER2 Gene Amplification in Breast Cancer by upQMPSF
- تاريخ النشر: 2017-09-22
ملخص البحث:
The amplification of human epidermal growth factor receptor 2 (HER2) gene in breast cancer identifies patients eligible for Trastuzumab therapy. immunohistochemistry (IHC) and/or fluorescent in situ hybridization (FISH) are the only FDA approved techniques for evaluating HER2 status. However, Interobserver variability is still a dilemma
الناشرون:
![](https://au.edu.sy/storage/upload/image/person-260-230s/39ekdg9g8td5_image_سامي ازرق.jpeg)
سامي أزرق
![](https://au.edu.sy/images/avatar.jpeg)
بتول الأعسر
![](https://au.edu.sy/images/avatar.jpeg)
ثائر خوري
- رابط المجلة:
Journal of Genetics and Genetic Engineering